<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02758041</url>
  </required_header>
  <id_info>
    <org_study_id>SEB-0294CH, SEB-0400</org_study_id>
    <nct_id>NCT02758041</nct_id>
  </id_info>
  <brief_title>A Study to Evaluate Sebacia Microparticles in Patients With Inflammatory Acne Vulgaris</brief_title>
  <official_title>A Study to Evaluate Sebacia Microparticles in Patients With Inflammatory Acne Vulgaris</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sebacia, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sebacia, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is proposed to evaluate Sebacia Microparticle treatment in patients with facial
      inflammatory acne vulgaris.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 2016</start_date>
  <completion_date type="Actual">February 2017</completion_date>
  <primary_completion_date type="Actual">January 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percent reduction in lesion count from baseline</measure>
    <time_frame>Baseline, Week 12, Week 24, Week 36</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Improvement in Investigator Global Acne Score</measure>
    <time_frame>Baseline, Week 12, Week 24, Week 36</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">85</enrollment>
  <condition>Facial Acne Vulgaris</condition>
  <arm_group>
    <arm_group_label>Sebacia Microparticles</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sebacia Microparticles</intervention_name>
    <arm_group_label>Sebacia Microparticles</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Male or female, 16-45 years of age.

          2. Moderate to moderately-severe facial inflammatory acne vulgaris

          3. Fitzpatrick skin phototype I-III

        Exclusion Criteria:

          1. Pregnant, lactating, nursing or planning to become pregnant

          2. Tattoo in the treatment area

          3. Active skin disease, excessive scarring or excess facial hair in the treatment area

          4. Certain current or recent acne treatments

          5. Recent light treatments including Intense Pulsed Light or other lasers,
             microdermabrasion or chemical peels in the treatment area

          6. Contraindicated for laser treatment, or is unable or unwilling to avoid excessive sun
             exposure or tanning bed use

          7. Known allergy to gold
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Merete Haedersdal, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Dermatology, Bispebjerg Hospital, Univ of Copenhagen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Lasercenter North</name>
      <address>
        <city>Aalborg</city>
        <zip>9220</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Dermatology, Bispebjerg Hospital, Univ of Copenhagen</name>
      <address>
        <city>Copenhagen</city>
        <zip>2400</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>SKINPULSE Dermatology Laser &amp; Beauty Center</name>
      <address>
        <city>Geneva</city>
        <zip>1205</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 19, 2016</study_first_submitted>
  <study_first_submitted_qc>April 27, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 2, 2016</study_first_posted>
  <last_update_submitted>September 5, 2017</last_update_submitted>
  <last_update_submitted_qc>September 5, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 7, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Acne</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acne Vulgaris</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

